Tag: licensing
-
Protein Drug Discovery Company Launches, Gains $50M
A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins.
-
Asthma Drug Tested as Alcoholism Treatment
Results from a small-scale clinical trial show an established drug to treat asthma and other inflammatory conditions has promise as a treatment for alcohol dependence.
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Simpler Lab Cell Production Techniques Devised
A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research.
-
Lilly Acquires Migraine Therapy Company in $960M Deal
Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms.
-
Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery
Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
FDA Approves Spinal Muscular Atrophy Drug [Updated]
A drug to treat spinal muscular atrophy, a genetic disorder causing the wasting away of muscle tissue in children and adults, was approved for sale in the U.S.
-
Smartphone System Shown to Control Blood Glucose Levels
A bionic pancreas system using a smartphone was shown in a clinical trial to control blood glucose levels better than a commercial insulin pump in persons with type 1 diabetes.